OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Bone and Mineral Research is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Prevalence and trends in low femur bone density among older US adults: NHANES 2005–2006 compared with NHANES III	189
Opportunistic Screening Using Low-Dose CT and the Prevalence of Osteoporosis in China: A Nationwide, Multicenter Study	103
Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop	103
Postpubertal Architectural Developmental Patterns Differ Between the L3 Vertebra and Proximal Tibia in Three Inbred Strains of Mice	96
Burosumab for the Treatment of Tumor-Induced Osteomalacia	82
Osteoporosis Management in the Era of COVID-19	82
Machine Learning Solutions for Osteoporosis—A Review	81
Bone Vasculature and Bone Marrow Vascular Niches in Health and Disease	81
Sclerostin Regulation, Microarchitecture, and Advanced Glycation End-Products in the Bone of Elderly Women With Type 2 Diabetes	75
Skeletal Biology and Disease Modeling in Zebrafish	74
Hypoxic Regulation of Mitochondrial Metabolism and Mitophagy in Nucleus Pulposus Cells Is Dependent on HIF-1α–BNIP3 Axis	70
Effects of High-Intensity Resistance Training on Osteopenia and Sarcopenia Parameters in Older Men with Osteosarcopenia—One-Year Results of the Randomized Controlled Franconian Osteopenia and Sarcopen	69
Treatment with Zoledronate Subsequent to Denosumab in Osteoporosis: a Randomized Trial	63
Bone Elasticity and Ultrasound Velocity Are Affected by Subtle Changes in the Organic Matrix	62
Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo-Controlled Trial	59
Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases	59
Racial and Ethnic Disparities in Bone Health and Outcomes in the United States	57
The diverse origin of bone-forming osteoblasts	56
Piezo1 Inactivation in Chondrocytes Impairs Trabecular Bone Formation	54
Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance Study	51
Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism	50
Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis: A 2-Year Randomized Study	47
Risk of Osteonecrosis of the Jaw Under Denosumab Compared to Bisphosphonates in Patients With Osteoporosis	47
The Effect of Fall Biomechanics on Risk for Hip Fracture in Older Adults: A Cohort Study of Video-Captured Falls in Long-Term Care	47
Interim Analysis of a Phase 2 Open-Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor-Induced Osteomalacia	46

Intracellular Accumulation of Advanced Glycation End Products Induces Osteoblast Apoptosis Via Endoplasmic Reticulum Stress	45
Safety of Oral Bisphosphonates in Moderate-to-Severe Chronic Kidney Disease: A Binational Cohort Analysis	43
Runx2 Regulates Mouse Tooth Root Development Via Activation of WNT Inhibitor NOTUM	42
Murine Tissue-Resident PDGFRα+ Fibro-Adipogenic Progenitors Spontaneously Acquire Osteogenic Phenotype in an Altered Inflammatory Environment	40
Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts	39
Burden of Illness in Adults With Hypophosphatasia: Data From the Global Hypophosphatasia Patient Registry	38
Ectopic Calcification and Hypophosphatemic Rickets: Natural History of ENPP1 and ABCC6 Deficiencies	38
Single-Cell RNA Sequencing of Calvarial and Long-Bone Endocortical Cells	38
Sex- and Site-Specific Reference Data for Bone Microarchitecture in Adults Measured Using Second-Generation HR-pQCT	37
Metabolomics Insights into Osteoporosis Through Association With Bone Mineral Density	37
Glutamine Metabolism in Osteoprogenitors Is Required for Bone Mass Accrual and PTH-Induced Bone Anabolism in Male Mice	37
lncRNA Neat1 Stimulates Osteoclastogenesis Via Sponging miR-7	36
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With	36